DRUG AND GENE DELIVERY DEVICES MARKET ANALYSIS
Global Drug and Gene Delivery Devices Market: Key Developments
In November 2022, IMUNON, Inc. and Acuitas Therapeutics signed an agreement to evaluate the combination of IMUNON’s PLACCINE nucleic acid vaccine constructs formulated with Acuitas’ proprietary lipid delivery technology.
In August 2022, Versant Ventures launched Vector BioPharma AG, a biopharmaceutical company developing a precision gene delivery platform devoid of viral genes.
In June 2022, Gufic Biosciences Ltd. launched a new drug delivery system, Dual Chamber Bags, at affordable prices for the first time in India.
In February 2022, Takeda received the U.S. Food and Drug Administration (USFDA) approval for TAKHZYRO (lanadelumab-flyo) injection, a single-dose prefilled syringe (PFS), to prevent attack of hereditary angioedema (HAE) in adult and pediatric patients 12 years of age and older.
Need a Custom Report?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Credibility and Certifications
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
U.S.: 
U.K. : 
India : 
